UNITED STATES SURGICAL CORP
8-K, 1998-02-11
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: USX CORP, SC 13G/A, 1998-02-11
Next: CRESTAR FINANCIAL CORP, SC 13G, 1998-02-11



<PAGE>   1
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): January 30, 1998

                       UNITED STATES SURGICAL CORPORATION
             (Exact name of registrant as specified in its charter)

DELAWARE                                 1-9776                 13-2518270
(State or other jurisdiction         (Commission File        (I.R.S. Employer
of incorporation)                         Number)         Identification Number)

                      150 GLOVER AVENUE, NORWALK, CT 06856
                    (Address of principal executive offices)

                                 (203) 845-1000
              (Registrant's telephone number, including area code)
<PAGE>   2
Item 5.           Other Events.

         The Registrant is filing herewith the press release issued by the
Registrant on January 30, 1998.


(c)      Exhibits

Exhibit 99.1.     Press Release dated January 30, 1998.

<PAGE>   3
                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                         UNITED STATES SURGICAL CORPORATION

Date:  February 10, 1998               By:  /s/ Richard A. Douville
                                            --------------------------------
                                            Richard A. Douville
                                            Senior Vice President and
                                            Chief Financial Officer
                                            (Principal Financial Officer)

<PAGE>   1
                                                                    EXHIBIT 99.1


<PAGE>   2
FOR IMMEDIATE RELEASE: January 30, 1998


INVESTOR CONTACT:             U.S. SURGICAL HOME PAGE:     MEDIA CONTACT:
Marianne Scipione             http://www.ussurg.com        Steve Rose
Vice President                                             Director
Corporate Communications                                   Media Relations
203-845-1404                                               203-845-1732
[email protected]                               [email protected]

                     U.S. SURGICAL COMPLETES ACQUISITION OF

                               PFIZER'S VALLEYLAB


     NORWALK, Conn. -- United States Surgical Corporation (NYSE:USS) announced
today that it has completed its acquisition of Valleylab, a division of Pfizer
Inc. (NYSE:PFE) for $425 million in cash. Valleylab is the world leader in
electrosurgical and ultrasonic products, with sales of approximately $200
million.

     Leon C. Hirsch, chairman of USS, said, "Valleylab is an ideal fit with
USS; our product lines, manufacturing capabilities, research and development
programs and sales organizations can be easily integrated, providing growth for
the parent company and its new division. We look forward to welcoming the
Valleylab family to USS."

     Valleylab owns a large, modern state-of-the art manufacturing facility in
Boulder, Colorado. USS plans to continue this operation and expand it by
integrating the manufacture of newly developed USS products.

     United States Surgical Corporation is a diversified medical products
company specializing in minimally invasive technologies that improve patient
care and lower health care costs.

                                    #  #  #


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission